Earlier this week, Insulet announced a voluntary medical device correction and recall for specific Omnipod 5 pod lots in the US after detecting a manufacturing defect that can cause insulin ...
Insulet recalled some lots of Omnipod 5 insulin pods because of potential leaking that could prevent users from getting full insulin doses. For people with diabetes, not getting enough insulin could ...
A tear in the tubing of the Omnipod 5 pods may prevent users from getting full insulin doses, raising the risk of serious adverse events from uncontrolled high blood sugar. Insulet recalled some lots ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Acton-based company received ...
Insulet ( (PODD)) has provided an announcement. On March 12, 2026, Insulet initiated a voluntary medical device correction in the U.S. for specific lots of its Omnipod 5 Pods after product monitoring ...
The affected lots represent approximately 1.5% of annual Omnipod 5 pod production globally and were distributed in the United States. All other Omnipod 5 Pods and Omnipod products remain unaffected by ...
Medical Device Correction impacts only specific lots of Omnipod® 5 Pods Customers can visit omnipod.com/check-pods to check lot numbers and request replacement Pods ...
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”) today initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue ...
ACTON, Mass., March 12, 2026--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company") today initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 ...
Omnipod Discover is being introduced in these Middle Eastern markets first, with plans to expand to other countries where Omnipod 5 is available. With these new market launches, Omnipod 5 is now ...
Expansion follows successful multi-year pilots in Massachusetts and California, and longstanding Pod takeback programs in Europe, Canada, and Australia Insulet Corporation (NASDAQ: PODD) (“Insulet” or ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. An updated algorithm for the Omnipod 5 automated insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results